Phone app to help manage blood clots in veins
Tests a phone app for preventing venous thromboembolism in adults at high risk.
Key facts
- Who runs it
- Navy General Hospital, Beijing
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Smart Technology Facilitated Patient-centered Venous Thromboembolism Management
- Status
- Not yet recruiting
- People taking part
- 2,353 people, planned
- Started
- 1 Nov 2024
- Expected to end
- 31 Oct 2027
- Type of study
- Interventional
- Treatments tested
- mobile venous thromboembolism application (mVTEA)
- Record updated
- 17 July 2024
Who can take part
The trial is looking for adults in hospital who have a high risk of blood clots in the veins (VTE) when they go home. They will use a phone app to help manage this risk.
- Age
- 18 years and older at admission.
- Sex
- All sexes.
- Disease stage
- High risk of VTE at discharge: Padua score ≥4 for medical patients, or Caprini score ≥5 for surgical patients.
- Main reasons for not taking part
- Diagnosed with VTE at discharge.
- Mental disorder or other serious disease that stops you from living on your own.
- Unable to use smartphones, tablets or other smart devices.
- Pregnant or breastfeeding.
- Took part in similar trials before, or now in another clinical trial.
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Inpatients ≥18 years of age at admission
- At high-risk of VTE at discharge: Padua score ≥4 for medical patients and Caprini score ≥5 for surgical patients
- Signed informed consent
Who cannot take part
- Mental disorder or combination of other serious diseases leading to incapacity for independent living
- Diagnosis of VTE at discharge
- Inability to use smartphones, computer tablets and other smart devices
- Being pregnant or breastfeeding
- Have participated in similar trials or are undergoing other clinical trials
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Venous thromboembolism or digital health or health education
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention.
Read full original descriptionShow less
The objective of this study is to observe the long-term effect of mobile venous thromboembolism application (mVTEA) based patient-centered management of venous thromboembolism (VTE) on thromboprophylaxis, and establish a foundation of evidence for managing patients with high-risk VTE.
The group in the trial
- mVTEA Management GroupTreatment being tested
Patients with high-risk of VTE will be discharged with mVTEA-assisted patient-centered VTE management.
Treatment: mobile venous thromboembolism application (mVTEA)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Smart Technology Facilitated Patient-centered Venous Thromboembolism Management: A Multicenter Cohort Study
- Plain-language title
- Phone app to help manage blood clots in veinsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06350344, who can take part
- Record updated
- 17 July 2024